Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
Clinical trial NCT06407947 · RECRUITING
Trial details
- NCT number
- NCT06407947
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-06
- Primary completion
- 2027-06-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.